ERBITUX
Drug
Lilly USA, LLC
Total Payments
$437,689
Transactions
5,708
Doctors
2,602
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $16.78 | 1 | 1 |
| 2023 | $105.42 | 3 | 3 |
| 2022 | $15,269 | 12 | 12 |
| 2021 | $22,807 | 823 | 592 |
| 2020 | $15,953 | 553 | 456 |
| 2019 | $102,240 | 1,425 | 818 |
| 2018 | $137,537 | 382 | 151 |
| 2017 | $143,762 | 2,509 | 1,377 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $272,738 | 161 | 62.3% |
| Food and Beverage | $90,571 | 5,332 | 20.7% |
| Consulting Fee | $51,600 | 49 | 11.8% |
| Unspecified | $11,964 | 2 | 2.7% |
| Travel and Lodging | $9,992 | 152 | 2.3% |
| Education | $824.80 | 12 | 0.2% |
Payments by Type
General
$425,725
5,706 transactions
Research
$11,964
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DUAL INHIBITION OF THE JAK STAT 3 CASCADE IN COMBINATION WITH RADIATION FOR HEAD AND NECK CANCER | E.R. Squibb & Sons, L.L.C. | $11,720 | 0 |
| PhIII Stage 3 4 Resectable Mel Adj Rela Nivo vs Nivo | E.R. Squibb & Sons, L.L.C. | $243.96 | 0 |
Top Doctors Receiving Payments for ERBITUX — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , PA-C | Medical | Austin, TX | $1,200 | 1 |
| , M.D | Medical Oncology | Jacksonville, FL | $984.71 | 4 |
| , MD | Hematology & Oncology | Caguas, PR | $955.51 | 6 |
| , M.D | Medical Oncology | Newnan, GA | $415.00 | 2 |
| , M.D | Radiation Oncology | Newark, DE | $341.22 | 2 |
| , M.D | Hematology & Oncology | Miami, FL | $274.47 | 11 |
| , MD | Hematology & Oncology | Miami, FL | $240.00 | 2 |
| , M.D | Medical Oncology | Cypress, TX | $234.06 | 12 |
| , MD | Hematology & Oncology | Sumter, SC | $209.42 | 9 |
| , M.D. PH.D | Hematology & Oncology | Los Angeles, CA | $205.41 | 12 |
| , MD | Hematology & Oncology | Sterling Heights, MI | $204.24 | 13 |
| , DO | Internal Medicine | Palm Springs, CA | $194.94 | 2 |
| , MD | Specialist | Alhambra, CA | $194.44 | 12 |
| , M.D | Hematology & Oncology | Barceloneta, PR | $193.87 | 9 |
| , M.D | Hematology & Oncology | Glendale, CA | $192.61 | 10 |
| , DO | Hematology & Oncology | Camp Hill, PA | $189.45 | 2 |
| , M.D | Hematology & Oncology | Rockledge, FL | $188.75 | 8 |
| , M.D | Hematology & Oncology | Terre Haute, IN | $184.70 | 7 |
| , M.D | Internal Medicine | Terre Haute, IN | $182.19 | 7 |
| Jingdong Su | Internal Medicine | Jacksonville, TX | $180.14 | 3 |
| , MD | Hematology & Oncology | San Juan, PR | $179.48 | 10 |
| , M.D | Hematology & Oncology | Beverly Hills, CA | $174.84 | 4 |
| , M.D | Hematology & Oncology | San Juan, PR | $174.45 | 9 |
| , M.D | Medical Oncology | Sebastian, FL | $171.19 | 6 |
| Rafael Gallardo | — | Terre Haute, IN | $171.07 | 6 |
Ad
Manufacturing Companies
- Lilly USA, LLC $422,028
- E.R. Squibb & Sons, L.L.C. $12,101
- Eli Lilly and Company $1,850
- Eli Lilly Export S.A. Puerto Rico Branch $1,710
Product Information
- Type Drug
- Total Payments $437,689
- Total Doctors 2,602
- Transactions 5,708
About ERBITUX
ERBITUX is a drug associated with $437,689 in payments to 2,602 healthcare providers, recorded across 5,708 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2017 to 2024. In 2024, $16.78 was paid across 1 transactions to 1 doctors.
The most common payment nature for ERBITUX is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($272,738, 62.3% of total).
ERBITUX is associated with 2 research studies, including "DUAL INHIBITION OF THE JAK STAT 3 CASCADE IN COMBINATION WITH RADIATION FOR HEAD AND NECK CANCER" ($11,720).